PhagePro

PhagePro is developing phage treatments to solve the globe’s largest health disparities and antibiotic resistance. As bacteria build resistance to antibiotics, alternative killing methods are required. Phages are natural hunters of bacteria. PhagePro is exploiting this power of phages to reduce the burden of antimicrobial resistance in emerging markets. As the phages only target bacteria, they are safe to humans and more specific than antibiotics. In addition, PhagePro is prioritizing stakeholder relationships to understand needs and incorporate them into their strategies to increase adoption on a global scale.

Jobs: